The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The very early tumor regression rate and safety of anlotinib combined with sintilimab and chemotherapy for advanced non-small cell lung cancer without driver mutations.
 
Jian Jiang
No Relationships to Disclose
 
Yuming Jia
No Relationships to Disclose
 
Yue Ren
No Relationships to Disclose
 
Ting Li
No Relationships to Disclose
 
Lei-Ya Du
No Relationships to Disclose
 
Mao-Qiong Jiang
No Relationships to Disclose
 
Ye Qiu
No Relationships to Disclose
 
Jie Chen
No Relationships to Disclose
 
Jun Yan
No Relationships to Disclose
 
Li Li
No Relationships to Disclose